Loading…
Loading…
EQUITY / NASDAQ · XNCM
Aethlon Medical Inc
01 / RESEARCH
8 financial reports are available for research.
Start research ↗6.52 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 6.52 USD · Volume 118,508
252 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2027 / Quarter 1 | 2026 / Quarter 1 | Change |
|---|---|---|---|
| Capital expenditures | 9,150 USD | 0 USD | — |
| Cash and cash equivalents | 4,933,579 USD | 3,765,154 USD | +31.03% |
| Financing cash flow | 1,817,155 USD | -5,357 USD | — |
| Investing cash flow | -9,150 USD | 0 USD | — |
| Net income | -1,547,912 USD | -1,761,858 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2027 / Quarter 1ConsolidatedUnits · USD | 2026 / Quarter 1ConsolidatedUnits · USD | 2026 / Year endConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 3ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 1ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Capital expendituresCash flow statement | 9,150 USD | — | 3,704 USD | — | 1,653 USD | — | — | 0 USD |
| Cash and cash equivalentsBalance sheet | 4,933,579 USD | 5,026,458 USD | 5,026,458 USD | 6,956,397 USD | — | — | — | 3,765,154 USD |
| Financing cash flowCash flow statement | 1,817,155 USD | — | 6,521,904 USD | — | 6,718,400 USD | — | 3,735,765 USD | -5,357 USD |
| Investing cash flowCash flow statement | -9,150 USD | — | -3,704 USD | — | -1,653 USD | — | — | 0 USD |
| Net incomeIncome statement | -1,547,912 USD | — | -7,151,469 USD | -2,018,245 USD | -5,267,203 USD | -1,487,100 USD | -3,248,958 USD | -1,761,858 USD |
| Operating cash flowCash flow statement | -1,896,539 USD | — | -6,998,392 USD | — | -5,248,011 USD | — | -3,373,654 USD | -1,714,937 USD |
| Operating profitIncome statement | -1,579,202 USD | — | -7,293,631 USD | -2,062,116 USD | -5,364,335 USD | — | -3,302,220 USD | -1,792,390 USD |
| Total assetsBalance sheet | 6,235,371 USD | 6,333,107 USD | 6,333,107 USD | 8,057,128 USD | — | — | — | — |
| Total equityBalance sheet | 5,199,329 USD | 4,886,272 USD | 4,886,272 USD | 6,713,097 USD | — | 5,745,977 USD | — | 3,423,513 USD |
| Total liabilitiesBalance sheet | — | — | 1,446,835 USD | 1,344,031 USD | — | — | — | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 06/10/2026 | Open report ↗ Published: 02/12/2026 | Open report ↗ Published: 02/12/2026 | Open report ↗ Published: 02/12/2026 | Open report ↗ Published: 11/12/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.